Literature DB >> 21680199

New insights into insulin resistance in the diabetic heart.

Susan Gray1, Jason K Kim.   

Abstract

Insulin resistance is a major characteristic of obesity and type 2 diabetes, and develops in multiple organs, including the heart. Compared with its role in other organs, the physiological role of insulin resistance in the heart is not well understood. The heart uses lipid as a primary fuel, but glucose becomes an important source of energy in ischemia. The impaired ability to utilize glucose might contribute to cell death and abnormal function in the diabetic heart. Recent discoveries regarding the role of inflammation, mitochondrial dysfunction and endoplasmic reticulum (ER) stress in obesity have advanced our understanding of how insulin resistance develops in peripheral organs. In this review, we examine these findings in relation to the diabetic heart to provide new insights into the mechanism of cardiac insulin resistance.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21680199      PMCID: PMC3183400          DOI: 10.1016/j.tem.2011.05.001

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  108 in total

1.  MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice.

Authors:  Denghong Zhang; Riccardo Contu; Michael V G Latronico; Jianlin Zhang; Jian Ling Zhang; Roberto Rizzi; Daniele Catalucci; Shigeki Miyamoto; Katherine Huang; Marcello Ceci; Yusu Gu; Nancy D Dalton; Kirk L Peterson; Kun-Liang Guan; Joan Heller Brown; Ju Chen; Nahum Sonenberg; Gianluigi Condorelli
Journal:  J Clin Invest       Date:  2010-07-19       Impact factor: 14.808

2.  mTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophy.

Authors:  Xiaoxiao Song; Yoichiro Kusakari; Chun-Yang Xiao; Stuart D Kinsella; Michael A Rosenberg; Marielle Scherrer-Crosbie; Kenta Hara; Anthony Rosenzweig; Takashi Matsui
Journal:  Am J Physiol Cell Physiol       Date:  2010-09-22       Impact factor: 4.249

3.  Lipotoxic heart disease in obese rats: implications for human obesity.

Authors:  Y T Zhou; P Grayburn; A Karim; M Shimabukuro; M Higa; D Baetens; L Orci; R H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

Review 4.  mTOR: from growth signal integration to cancer, diabetes and ageing.

Authors:  Roberto Zoncu; Alejo Efeyan; David M Sabatini
Journal:  Nat Rev Mol Cell Biol       Date:  2010-12-15       Impact factor: 94.444

5.  Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice.

Authors:  C T Coburn; F F Knapp; M Febbraio; A L Beets; R L Silverstein; N A Abumrad
Journal:  J Biol Chem       Date:  2000-10-20       Impact factor: 5.157

Review 6.  Muscle insulin resistance: assault by lipids, cytokines and local macrophages.

Authors:  Girish Kewalramani; Philip J Bilan; Amira Klip
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2010-07       Impact factor: 4.294

7.  Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart.

Authors:  E D Abel; H C Kaulbach; R Tian; J C Hopkins; J Duffy; T Doetschman; T Minnemann; M E Boers; E Hadro; C Oberste-Berghaus; W Quist; B B Lowell; J S Ingwall; B B Kahn
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

Review 8.  Mitochondria in the diabetic heart.

Authors:  Heiko Bugger; E Dale Abel
Journal:  Cardiovasc Res       Date:  2010-07-16       Impact factor: 10.787

9.  Prolonged fasting identifies skeletal muscle mitochondrial dysfunction as consequence rather than cause of human insulin resistance.

Authors:  Joris Hoeks; Noud A van Herpen; Marco Mensink; Esther Moonen-Kornips; Denis van Beurden; Matthijs K C Hesselink; Patrick Schrauwen
Journal:  Diabetes       Date:  2010-06-23       Impact factor: 9.461

10.  Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERalpha-deficient mice.

Authors:  Vicent Ribas; M T Audrey Nguyen; Darren C Henstridge; Anh-Khoi Nguyen; Simon W Beaven; Matthew J Watt; Andrea L Hevener
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-11-17       Impact factor: 4.310

View more
  37 in total

1.  Beta-blocker timolol alleviates hyperglycemia-induced cardiac damage via inhibition of endoplasmic reticulum stress.

Authors:  Figen Amber Cicek; Aysegul Toy; Erkan Tuncay; Belgin Can; Belma Turan
Journal:  J Bioenerg Biomembr       Date:  2014-07-27       Impact factor: 2.945

Review 2.  Maternal diet, bioactive molecules, and exercising as reprogramming tools of metabolic programming.

Authors:  Paulo C F Mathias; Ghada Elmhiri; Júlio C de Oliveira; Carine Delayre-Orthez; Luiz F Barella; Laize P Tófolo; Gabriel S Fabricio; Abalo Chango; Latifa Abdennebi-Najar
Journal:  Eur J Nutr       Date:  2014-01-28       Impact factor: 5.614

Review 3.  Molecular and metabolic mechanisms of cardiac dysfunction in diabetes.

Authors:  Chirag H Mandavia; Annayya R Aroor; Vincent G Demarco; James R Sowers
Journal:  Life Sci       Date:  2012-11-09       Impact factor: 5.037

4.  Does resveratrol improve insulin signaling in chronically ischemic myocardium?

Authors:  Ashraf A Sabe; Nassrene Y Elmadhun; Michael P Robich; Rahul S Dalal; Frank W Sellke
Journal:  J Surg Res       Date:  2013-03-29       Impact factor: 2.192

Review 5.  Diabetic cardiomyopathy: bench to bedside.

Authors:  Joel D Schilling; Douglas L Mann
Journal:  Heart Fail Clin       Date:  2012-08-09       Impact factor: 3.179

Review 6.  Insulin resistance and heart failure: molecular mechanisms.

Authors:  Annayya R Aroor; Chirag H Mandavia; James R Sowers
Journal:  Heart Fail Clin       Date:  2012-08-09       Impact factor: 3.179

Review 7.  Is diabetic cardiomyopathy a specific entity?

Authors:  Mitja Letonja; Danijel Petrovič
Journal:  World J Cardiol       Date:  2014-01-26

8.  Short-term weight loss attenuates local tissue inflammation and improves insulin sensitivity without affecting adipose inflammation in obese mice.

Authors:  Dae Young Jung; Hwi Jin Ko; Eben I Lichtman; Eunjung Lee; Elizabeth Lawton; Helena Ong; Kristine Yu; Yoshihiro Azuma; Randall H Friedline; Ki Won Lee; Jason K Kim
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-03-12       Impact factor: 4.310

Review 9.  Disruption of energy utilization in diabetic cardiomyopathy; a mini review.

Authors:  Shinsuke Nirengi; Carmem Peres Valgas da Silva; Kristin I Stanford
Journal:  Curr Opin Pharmacol       Date:  2020-09-25       Impact factor: 5.547

10.  Cardiac expression of human type 2 iodothyronine deiodinase increases glucose metabolism and protects against doxorubicin-induced cardiac dysfunction in male mice.

Authors:  Eun-Gyoung Hong; Brian W Kim; Dae Young Jung; Jong Hun Kim; Tim Yu; Wagner Seixas Da Silva; Randall H Friedline; Suzy D Bianco; Stephen P Seslar; Hiroko Wakimoto; Charles I Berul; Kerry S Russell; Ki Won Lee; P Reed Larsen; Antonio C Bianco; Jason K Kim
Journal:  Endocrinology       Date:  2013-07-16       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.